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Egypt has possibly the highest Hepatitis C Virus (HCV)
prevalence worldwide. A high proportion of HCV infec-
tions become chronic and lead to liver cirrhosis and hepa-
tocellular carcinoma (HCC). The cellular and molecular
mechanisms behind the complication of HCV infection
are not completely understood although apoptosis has
been implicated in this process. We examined whether T
cells; isolated from patients with HCV and HCV-associ-
ated HCC (HCV-HCC); are predestined in vivo to
undergo spontaneous apoptosis using flow cytometry.
Also, the role of p53; a key in apoptotic process; in the
development of HCC was examined. Our data showed
that T cells were severely depleted in HCV-HCC patients
and its spontaneous apoptosis was higher in patient
groups as compared to normal controls as did the expres-
sion of p53, which correlated well with the HCC grade. In
conclusion, HCV infection induces peripheral T cell apop-
tosis, depletion and subsequently immune-suppression in
HCV patients and this may lead to persistence of infec-
tion. Also, p53 is implicated in the poor prognosis of
HCV-HCC and could be used as a biomarker to assess the
prognosis of HCC patients.
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